Mounjaro Pens Per Box: Understanding Your Supply for a Supported Weight Loss Journey

Last reviewed: July 16, 2026

Last updated: July 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a dual GLP-1 and GIP receptor agonist that has demonstrated superior weight loss outcomes compared to single-mechanism therapies in clinical trials. Understanding how your medication supply works—and how pricing remains stable as your treatment advances—helps you stay committed to your health goals without financial surprises.

How Tirzepatide Injection Supplies Work

Tirzepatide comes in pre-filled pens designed for once-weekly self-injection. Each pen contains a single dose, and your monthly supply depends on your current treatment stage. When you begin tirzepatide therapy, your starting dose is typically 2.5 mg weekly, which means one pen per week. As your body adapts and your prescriber adjusts your dose upward—progressing through 5 mg, 7.5 mg, 10 mg, and potentially higher maintenance doses—your medication needs may change, but your monthly cost remains exactly the same.

PlexusDx compounded tirzepatide is prepared by licensed 503A compounding pharmacies and shipped directly to you. This approach gives your treatment team flexibility to customize your dose based on your response and tolerance, rather than being locked into fixed pharmaceutical doses. You receive enough pens each month to match your current prescription, with clear refill reminders so you never run short during your weight loss journey.

Why Flat Monthly Pricing Supports Long-Term Adherence

Traditional tirzepatide pens (brand-name Mounjaro) often use a dose-ladder pricing model, meaning each strength increment costs more. This creates a financial barrier exactly when your treatment is working best and your prescriber wants to optimize your dose. PlexusDx eliminates this barrier with a single flat rate of $289 per month for compounded tirzepatide injection—whether you're taking 2.5 mg or a higher maintenance dose. Your dose may need to go up. Your price won't.

This pricing transparency reduces a major source of treatment abandonment. Patients who feel secure knowing their cost is predictable tend to stick with their therapy longer, which directly correlates with better weight loss outcomes and sustained metabolic improvements. Because PlexusDx serves all 50 states with no insurance required and no membership fees, you can start immediately and adjust your dose without worrying about your monthly budget shifting.

Managing Your Monthly Tirzepatide Injection Supply

Your PlexusDx account tracks your refill schedule automatically. Once you start compounded tirzepatide, you'll receive your pens every 28 days unless you or your prescriber adjust the frequency. Each shipment includes clear instructions for storage (refrigerate at 2–8°C until use) and administration. Because you're working with a dedicated prescriber, dose adjustments are coordinated through your account—you won't be left guessing whether to increase or when to refill.

If you experience any side effects or need to pause your therapy, PlexusDx makes it simple to communicate with your care team. Flexible pause and resume options mean you maintain continuity of care without losing your progress. HSA and FSA accounts can be used to pay for your tirzepatide supply, making your treatment even more accessible from a tax-advantage perspective.

Genetic Testing for Tirzepatide Response Optimization

PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway analysis that examines key genetic variants affecting your response to GLP-1 and GIP therapies. This test evaluates markers like GIPR rs1800437, FTO rs9939609, and MC4R rs17782313, among 150+ other genetic insights across 14 metabolic pathways. Understanding your genetic predisposition to peptide signaling helps your PlexusDx prescriber fine-tune your tirzepatide dose strategy from the start, potentially accelerating your results.

The Precision Peptide Genetic Test is available for $298. This timing allows you to start tirzepatide immediately while your provider gathers genetic data to personalize your dose progression. Patients who combine genetic insights with monthly supply monitoring tend to reach their goal weight faster and maintain their results with greater confidence.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many pens do I receive each month on compounded tirzepatide?

Your monthly pen count depends on your current dose and injection frequency. Most patients start with one 2.5 mg pen weekly (four pens per month), but your PlexusDx care team will adjust this based on your prescription. Each refill is timed to arrive before you run out, ensuring uninterrupted treatment.

Does my price increase if my tirzepatide dose goes up?

No. PlexusDx compounded tirzepatide injection is $289 per month flat, regardless of your dose level. This flat-rate model means you can optimize your treatment without financial penalties, supporting better long-term adherence and weight loss outcomes.

Can I use HSA or FSA to pay for PlexusDx tirzepatide?

Yes. Compounded tirzepatide from PlexusDx is HSA and FSA eligible, allowing you to use pre-tax dollars for your treatment. This reduces your effective out-of-pocket cost and makes personalized GLP-1 therapy more affordable.

What if I need to pause my tirzepatide supply temporarily?

PlexusDx offers flexible pause and resume options so you can adjust your treatment schedule without losing your progress or relationship with your prescriber. Simply contact your care team to modify your refill timing, and you can resume when ready.

How does the Precision Peptide Genetic Test help with tirzepatide dosing?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.